about
Schizophrenia relapse, patient considerations, and potential role of lurasidoneEfficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysisA Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic PathwayThe effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.The health benefits and challenges of exercise training in persons living with schizophrenia: a pilot study.Vitamin D Levels in Different Severity Groups of Schizophrenia.Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events.Food intake and blood cholesterol levels of community-based adults with mood disorders.Doing Damage in Delirium: The Hazards of Antipsychotic Treatment in Elderly Persons.Grand challenges: Integrating mental health care into the non-communicable disease agendaTardive and spontaneous dyskinesia incidence in the general population.Determination of olanzapine and N-desmethyl-olanzapine in plasma using a reversed-phase HPLC coupled with coulochemical detection: correlation of olanzapine or N-desmethyl-olanzapine concentration with metabolic parameters.Metformin and berberine prevent olanzapine-induced weight gain in ratsA chinese herbal formula to improve general psychological status in posttraumatic stress disorder: a randomized placebo-controlled trial on sichuan earthquake survivorsBrain in flames - animal models of psychosis: utility and limitationsMetacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study.Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.Cardiologic side effects of psychotropic drugs.The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.Emergency department visits by adults for psychiatric medication adverse eventsRole of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain.Comorbidity profile and healthcare utilization in elderly patients with serious mental illnessesIssues in the management of acute agitation: how much current guidelines consider safety?Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness.What about temperature? Haloperidol-induced hypotermia.Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem.Dyslipidaemia and Medical Outcome (Health Related Quality of Life) in Patients with Schizophrenia Taking Antipsychotics in Enugu, Nigeria.Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.Tardive Dyskinesia, Oral Parafunction, and Implant-Supported Rehabilitation.Olanzapine-induced tender pitting pre-tibial edema.Atypical antipsychotics and inverse agonism at 5-HT2 receptors.Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review.Lack of tolerable treatment options for patients with schizophrenia.Weight changes before and after lurasidone treatment: a real-world analysis using electronic health records.Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.Qualitative systematic review of barriers and facilitators to patient-involved antipsychotic prescribing.
P2860
Q26738850-BCDD5233-F064-49E3-B009-23D7497E39B5Q28650054-79C5AF6D-8439-4FBE-95A1-B7CDB7A955E6Q33607904-5684099E-2E8B-41D0-9BB5-DE8A3DF5C683Q33619940-B3B5C429-7F29-4FC9-BF06-EFADDDFCD37BQ33772123-F535FD28-F908-4043-B18E-18DA341321AEQ33790336-1419C565-5345-4B88-8AB9-B2B652D1A612Q34154208-F8A305A5-3D3D-44EE-920A-23D5DEA3E136Q34158786-F733A455-5140-414D-9CBD-FD5ED369450AQ34267707-CE48C1C5-10E0-4649-A097-C663AD25E333Q34729679-6850059E-F30C-45FE-896F-2566AD33226BQ34743134-CAD0D569-C870-4589-B2A7-B5224CA23D6AQ34761472-962C4E78-541F-498E-9A2C-C4B0E9DD31C9Q35131343-95DEE55C-7691-4FAA-97A4-AB3E1CAF0251Q35418015-1ECD47E1-DEC9-4222-8871-5D580C709FD8Q35683865-DD495FFB-85F4-4A00-A553-ACD68C47E3BEQ35833671-629700D6-7BCD-4B44-BF76-D061FEF8F279Q35929403-B81FDC47-8094-403F-AF9A-0F0F1EE8DCBBQ36077336-4E62F868-8B58-404D-8D50-9754C4F38173Q36321595-6E67AF2B-B4E5-4C6F-915D-38453D2CDD34Q36436410-C3829CC7-7E95-4F26-A544-C8073F62C063Q36441507-490B9137-1FF9-4B06-BB67-7D12F068D0C2Q36609245-78833039-48F7-46A8-81B1-CD59988A4EC0Q36821982-2564519A-2320-4EC9-A755-72E9EA59FE24Q36987106-9788465D-21EB-4972-AE55-3ED32415688DQ37223701-95845954-D16D-4C69-A53C-9B271DBF1AA9Q37632244-7F0B8383-4A66-47ED-B11A-9D4AFC0F4B97Q37681620-3F94BBCD-D76F-42D7-8FE0-83FFE7827E66Q38663135-16F95843-5BB3-4A8B-B24F-9854983A3870Q39380550-4BB54101-9373-4DE6-8420-673A5BB34FBCQ40250413-82E9DCE7-CDF1-45CE-B897-7205B4C66ED7Q41250110-ADD839A5-8F57-4EF3-8D35-3E3F9D64E3DAQ41633896-8C51B8ED-1155-4EFB-AB6D-2324E3CE486BQ42120078-C1DD08CD-F47B-47F6-B5D9-111F3882CF6BQ42682470-49A12DF2-8267-4DAC-9334-B32DBFA28DCBQ46133668-83B7AF7A-5677-4950-A7E3-D84BEB5A293DQ47549939-886F1715-0F2B-41DC-AB35-7B62DE5A364C
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adverse effects of antipsychotic medications.
@ast
Adverse effects of antipsychotic medications.
@en
Adverse effects of antipsychotic medications.
@nl
type
label
Adverse effects of antipsychotic medications.
@ast
Adverse effects of antipsychotic medications.
@en
Adverse effects of antipsychotic medications.
@nl
prefLabel
Adverse effects of antipsychotic medications.
@ast
Adverse effects of antipsychotic medications.
@en
Adverse effects of antipsychotic medications.
@nl
P1476
Adverse effects of antipsychotic medications.
@en
P2093
Ann M Hamer
John Muench
P304
P577
2010-03-01T00:00:00Z